Everolimus Zentiva 5 mg, Tabletten

7680680000021 CH-68000 Tabletten
Everolimus Zentiva 5 mg, Tabletten
Everolimus Zentiva 5 mg, Tabletten
Everolimus Zentiva 5 mg, Tabletten
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/03/2025
Patient information leaflet
Français
06/03/2025
Patient information leaflet
Italien
06/03/2025
Summary of Product Characteristics
Allemand
11/01/2025
Summary of Product Characteristics
Français
11/01/2025
Summary of Product Characteristics
Italien
11/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
136.0 MG Substance HBESI
(N/A)
12.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 929.50
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2024

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
68000
Drug name
Everolimus Zentiva, Tabletten
Galenic form
TAB
ATC Code
L01EG02
Authorization status
Z
Dispensing category
A
First authorization
20/05/2021
Authorization expiration date
19/05/2026
IT Number
07.16.4.
Domain
Human medicine
Field of application
Brustkrebs, neuroendokrine Tumoren pankreatischen Ursprungs, neuroendokrine Tumoren gastrointestinalen oder pulmonalen Ursprungs, Nierenzellkarzinom

Package details

Description (FR)
EVEROLIMUS Zentiva cpr 5 mg 30 pce
Description (DE)
EVEROLIMUS Zentiva Tabl 5 mg 30 Stk
Market launch
20/05/2021
Narcotic (BTM)
No

Other package sizes (2)

EVEROLIMUS Zentiva cpr 2.5 mg 30 pce
30 TABL
GTIN: 7680680000014
View
EVEROLIMUS Zentiva cpr 10 mg 30 pce
30 TABL
GTIN: 7680680000038
View